Use of at least one cytosolic phospholipase a2 inhibitor as...

Details Use of at least one cytosolic phospholipase a2 inhibitor as... Use of at least one cytosolic phospholipase a2 inhibitor as...

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 31/12 (2006.01) A61K 31/121 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/43 (2006.01) A61K 31/661 (2006.01) A61K 45/06 (2006.01) A61P 11/00 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2648239

The purpose of this invention is the use of at least one cytosolic phospholipase A2 (cPLA2) inhibitor in the preparation of a medicine intended for preventive and/or remedial symptomatic treatment of mucoviscidosis, and particularly the increased secretion of mucus in mucoviscidosis.

L'invention a pour objet l'utilisation d'au moins un inhibiteur de la phospholipase A2 cytosolique (cPLA2) dans la préparation d'un médicament destiné au traitement symptomatique préventif et/ou curatif de la mucoviscidose particulièrement de la sécrétion accrue de mucus dans la mucoviscidose.

Affiliated with

Also associated with

Rating

Use of at least one cytosolic phospholipase a2 inhibitor as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of at least one cytosolic phospholipase a2 inhibitor as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of at least one cytosolic phospholipase a2 inhibitor as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1932276